The Global Challenge of Personalized MedicinesVideo Categories: Personalized Medicine
Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.
Linda Bosserman provides insight into positive data around payer-provider collaborations